Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Lonza is responsible for manufacturing proprietary tech components and Sidewinder for ADC, R&D, manufacturing, and commercialization.

Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "ADC Contract Manufacturing Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Stage of Development, Process Component, Target ...

Daiichi Sankyo plans to splash out some 300 billion yen ($1.9 billion) on Enhertu manufacturing facilities across the globe, ...

14 May 2018, Wales: ADC Biotechnology (ADC Bio), together with Maven Capital Partners and Bioscience Managers, is to host a webinar through ADC Review entitled ‘Investing for the future: unlocking ...

Antibody drug conjugates have fast become a big piece of AstraZeneca’s revenue growth. The drugmaker is taking steps to ensure it has the production capacity to meet market demand for these cancer ...

Basel, Switzerland, 8 January 2013 – Lonza today announced plans to invest CHF 14 million to expand Antibody Drug Conjugate (ADC) manufacturing capacity in Visp, Switzerland. Oncology therapeutics ...

DUBLIN--(BUSINESS WIRE)--The "ADC Contract Manufacturing Market (3rd Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering. The ADC Contract Manufacturing Market (3rd edition ...